ATE82135T1 - Synthetische hepatitis-b-virus-vakzine die tzellen- und b-zellenbestimmer enthalten. - Google Patents

Synthetische hepatitis-b-virus-vakzine die tzellen- und b-zellenbestimmer enthalten.

Info

Publication number
ATE82135T1
ATE82135T1 AT85301588T AT85301588T ATE82135T1 AT E82135 T1 ATE82135 T1 AT E82135T1 AT 85301588 T AT85301588 T AT 85301588T AT 85301588 T AT85301588 T AT 85301588T AT E82135 T1 ATE82135 T1 AT E82135T1
Authority
AT
Austria
Prior art keywords
cell
determiners
hepatitis
virus vaccine
vaccine containing
Prior art date
Application number
AT85301588T
Other languages
English (en)
Inventor
David R Milich
Frank V Chisari
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/588,122 external-priority patent/US4599230A/en
Priority claimed from US06/587,983 external-priority patent/US4599231A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE82135T1 publication Critical patent/ATE82135T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Selective Calling Equipment (AREA)
  • Air Bags (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT85301588T 1984-03-09 1985-03-07 Synthetische hepatitis-b-virus-vakzine die tzellen- und b-zellenbestimmer enthalten. ATE82135T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/588,122 US4599230A (en) 1984-03-09 1984-03-09 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US06/587,983 US4599231A (en) 1984-03-09 1984-03-09 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
EP85301588A EP0155146B1 (de) 1984-03-09 1985-03-07 Synthetische Hepatitis-B-Virus-Vakzine die T-Zellen- und B-Zellenbestimmer enthalten

Publications (1)

Publication Number Publication Date
ATE82135T1 true ATE82135T1 (de) 1992-11-15

Family

ID=27080174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85301588T ATE82135T1 (de) 1984-03-09 1985-03-07 Synthetische hepatitis-b-virus-vakzine die tzellen- und b-zellenbestimmer enthalten.

Country Status (11)

Country Link
EP (1) EP0155146B1 (de)
AT (1) ATE82135T1 (de)
AU (2) AU579148B2 (de)
CA (1) CA1253069A (de)
DE (1) DE3586801D1 (de)
DK (1) DK516385A (de)
FI (1) FI84558C (de)
IL (3) IL74545A (de)
NO (1) NO167359C (de)
NZ (2) NZ211356A (de)
WO (1) WO1985004103A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
JPH01500515A (ja) * 1986-06-20 1989-02-23 スクリップス　クリニック　アンド　リサーチ　ファウンデーション Ｂ型肝炎ウィルス表面抗原のプレｓ領域のｔ及びｂ細胞エピトープ
US6054438A (en) * 1987-01-07 2000-04-25 Imperial Cancer Research Technology Limited Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
AU1668788A (en) * 1987-05-26 1988-12-01 Wistar Institute, The Method of vaccination for hepatitis b virus
DE10299017I2 (de) * 1987-06-22 2005-05-25 Medeva Holdings Bv Hepatitis-B-Oberfl{chenantigen enthaltendes Peptid.
EP0375740A1 (de) * 1987-09-04 1990-07-04 Whitehead Institute For Biomedical Research Peptidkomplexe mit erhöhter stabilität
EP0491077A1 (de) * 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
GB9325772D0 (en) * 1993-12-16 1994-02-16 Smithkline Beecham Biolog Novel compounds
CA2251904A1 (en) * 1996-04-18 1997-10-23 Abbott Laboratories An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
WO1998012332A1 (en) 1996-09-17 1998-03-26 Chiron Corporation Compositions and methods for treating intracellular diseases
EP0948533A1 (de) * 1996-12-30 1999-10-13 Innogenetics N.V. Annexin v bindende polypeptidfragmente des hbsag und ihre verwendung
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
ES2330904B1 (es) 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.
ES2657480T3 (es) 2006-08-11 2018-03-05 Life Sciences Research Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
CA2715611C (en) 2008-02-14 2018-03-13 Life Sciences Research Partners Vzw Immunotherapy targeting intracellular pathogens
EP2623115A1 (de) 2008-02-14 2013-08-07 Life Sciences Research Partners VZW Immunogene Beeinflussung von Tumoren und Tumorzellen
HUE055070T2 (hu) 2010-11-25 2021-10-28 Imnate Sarl Immunogén peptidek fertõzõ betegségek, autoimmun betegségek, allofaktorokra adott immunválaszok, allergiás betegségek, tumorok, graftkilökõdés, és génterápiához vagy génvakcinációhoz alkalmazott vírusvektorokkal szembeni immunválaszok megelõzésében és/vagy kezelésében történõ alkalmazásra
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
CN103483421B (zh) * 2012-06-11 2019-10-22 厦门大学 用于治疗hbv感染及相关疾病的多肽及抗体
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
ES2874077T3 (es) 2015-09-25 2021-11-04 Imcyse Sa Métodos y compuestos mejorados para eliminar respuestas inmunitarias a agentes terapéuticos
KR20240015731A (ko) 2016-04-19 2024-02-05 임시스 에스에이 신규 면역원성 CD1d 결합 펩티드
JP6955020B2 (ja) 2017-02-17 2021-10-27 シャアメン ユニバーシティ 標的ポリペプチドを提示するためのポリペプチド担体及びその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
YU44186B (en) * 1978-12-22 1990-04-30 Biogen Nv Process for obtaining recombinant dnk molecules
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
DE3275998D1 (en) * 1981-12-22 1987-05-14 Baylor College Medicine Immunological composition and method for hepatitis b virus
US4483793A (en) * 1982-10-04 1984-11-20 The Regents Of The University Of California Dimeric oligopeptides as heptenic epitopic sites for hepatitis
JPS5974985A (ja) * 1982-10-19 1984-04-27 Takeda Chem Ind Ltd 新規ｄｎａ
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids

Also Published As

Publication number Publication date
IL90035A (en) 1990-11-05
DE3586801D1 (de) 1992-12-17
NO167359B (no) 1991-07-22
FI854396A (fi) 1985-11-07
DK516385D0 (da) 1985-11-08
FI84558C (fi) 1991-12-27
NZ227731A (en) 1990-07-26
IL90035A0 (en) 1989-12-15
AU4115985A (en) 1985-10-11
WO1985004103A1 (en) 1985-09-26
FI84558B (fi) 1991-09-13
EP0155146A2 (de) 1985-09-18
EP0155146B1 (de) 1992-11-11
AU2682388A (en) 1989-05-25
NZ211356A (en) 1990-07-26
CA1253069A (en) 1989-04-25
EP0155146A3 (en) 1988-01-20
AU579148B2 (en) 1988-11-17
NO167359C (no) 1991-10-30
NO854460L (no) 1986-01-08
AU623106B2 (en) 1992-05-07
IL74545A0 (en) 1985-06-30
DK516385A (da) 1985-11-08
IL74545A (en) 1990-11-05
FI854396A0 (fi) 1985-11-07

Similar Documents

Publication Publication Date Title
ATE82135T1 (de) Synthetische hepatitis-b-virus-vakzine die tzellen- und b-zellenbestimmer enthalten.
IL86832A0 (en) Recombinant dna molecules,host cells containing the same,immunogenic particles,pharmaceutical compositions containing the same and processes for the preparation thereof
LU91498I2 (fr) Etanercept et ses dérivés pharmaceutiquement acceptables.
OA07233A (fr) Interféron immunitaire humain.
IE873314L (en) T cell epitopes of the hepatitis b virus nucleocapsid¹protein
DE3650645D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
FI863041A (fi) Fusionsprotein, foerfarande foer deras framstaellning och deras anvaendning.
ES555124A0 (es) Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
DK0666914T3 (da) Hidtil ukendt P-selectin-ligandprotein
FI19992546A (fi) Hepatiitti B:n S- ja PreS2-proteiinien ilmentäminen metylotrofisissa hiivoissa
DE68924464D1 (de) Interferon-gamma bindende Proteine.
FI923020A (fi) Inte a inte b-sekvenser.
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
GR3006212T3 (de)
IS3511A7 (is) Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski
ES8801958A1 (es) Un procedimiento para la determinacion de virus de sida
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
KR890002399A (ko) 하이브리드 인터페론 및 재조합 dna기술을 이용한 그의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties